Offer - Urjas Oil for just ₹ 1 X
Virolans 150 Mg/40 Mg/200 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Other than this, Virolans 150 Mg/40 Mg/200 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Virolans 150 Mg/40 Mg/200 Mg Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Virolans 150 Mg/40 Mg/200 Mg Tablet as well, which are listed below. Such side effects of Virolans 150 Mg/40 Mg/200 Mg Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Virolans 150 Mg/40 Mg/200 Mg Tablet's effect during pregnancy is Moderate and Mild while nursing. Further, the section on Virolans 150 Mg/40 Mg/200 Mg Tablet related warnings talks about Virolans 150 Mg/40 Mg/200 Mg Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Kidney Disease, Pancreatitis, Liver Disease must refrain from the use of Virolans 150 Mg/40 Mg/200 Mg Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Virolans 150 Mg/40 Mg/200 Mg Tablet contraindications section.
Drug reaction of Virolans 150 Mg/40 Mg/200 Mg Tablet with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Virolans 150 Mg/40 Mg/200 Mg Tablet is not safe while driving, and is is not addictive in nature.
Virolans 150 Mg/40 Mg/200 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Virolans 150 Mg/40 Mg/200 Mg Tablet safe for pregnant women?
Virolans may have some side effects during pregnancy. Pregnant women should discontinue the use of Virolans, and talk to their doctor, if they notice any discomfort.
Is the use of Virolans 150 Mg/40 Mg/200 Mg Tablet safe during breastfeeding?
Side effects of Virolans for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Virolans 150 Mg/40 Mg/200 Mg Tablet on the Kidneys?
Virolans may have mild side effects on the kidneys.
What is the effect of Virolans 150 Mg/40 Mg/200 Mg Tablet on the Liver?
Virolans is rarely harmful for the liver.
What is the effect of Virolans 150 Mg/40 Mg/200 Mg Tablet on the Heart?
You can take Virolans without any fear of damage to the heart.
Virolans 150 Mg/40 Mg/200 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Virolans 150 Mg/40 Mg/200 Mg Tablet unless your doctor advises you to do so -
Is this Virolans 150 Mg/40 Mg/200 Mg Tablet habit forming or addictive?
Virolans 150 Mg/40 Mg/200 Mg Tablet is not addictive in nature.
Interaction between Food and Virolans 150 Mg/40 Mg/200 Mg Tablet
Some foods when eaten with Virolans 150 Mg/40 Mg/200 Mg Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Virolans 150 Mg/40 Mg/200 Mg Tablet
Taking alcohol with Virolans 150 Mg/40 Mg/200 Mg Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Viramune® (nevirapine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 809
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zerit® (stavudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807